This profile was last updated on .
Is this you? Claim your profile.
Rubin and Rudman LLP
50 Rowes Wharf
Rubin and Rudman's Energy Practice Group is one of the most experienced in New England, representing developers of renewable energy projects, as well as developers of conventional generation and transmission facilities. We also represent public power util...
Find other employees at this company (189)
(55 Total References)
Peter B. Finn, Esq., Secretary and Corporate Counsel
Mr. Finn is a Senior Partner at Rubin and Rudman, LLP in Boston.
practice is principally devoted to representing biotechnology and high technology companies in all aspects of corporate law, licensing and financing.
Mr. Finn received his BA degree from Syracuse University and his JD degree from the Boston College Law School.
is admitted to the Massachusetts Bar
, the United States District Court for the District of Massachusetts and the United States Court of Appeals
, First Circuit.
has authored articles related to financing, contracts, and licenses.
Mr. Finn was an invited lecturer at the Massachusetts Biotechnology Council.
has been associated with Hygeia Therapeutics
ViThera Co-founders Johannes Fruehauf and Philippe Langella are joined by CFO (part time) Lisa Velardo and a seasoned advisory team containing Peter D. Parker (BioInnovation, Cequent, Ampersand Ventures), Peter Finn (Rubin & Rudman).
Legal Counsel: Peter ...
Legal Counsel: Peter Finn
represents biotechnology and high technology companies in all aspects of corporate law, licensing and financing.
He is a partner at Rubin and Rudman and has led venture capital financings in excess of $500,000,000.
has established himself as a leading biotech lawyer in the Boston and Cambridge biotech cluster and has represented a wide variety of clients.
Evelexa BioResources: Legal Issues
Peter B. Finn, ESQ, Senior Partner
Rubin and Rudman LLP
Peter B. Finn, ESQ, Senior Partner, Rubin and Rudman LLP.
Mr. Finn is a Senior Partner with Rubin and Rudman LLP in Boston, MA, where he chairs the firmâ€™s Biotechnology Practice.
practice on representing start-up biotechnology and medical device companies, the development licenses, collaborations, and joint venture agreements, and all aspects of corporate finance.
He is a member of the Technology Transfer Committee of the Beth Israel Deaconess Medical Center and equity subcommittee and the Editorial Board of the Biolaw and Business Journal.
has authored and published: Material Transfer Agreements, A Battle of Forms, Negotiating and Drafting Confidentiality Agreements, and Structuring a Start-up for Venture Capital Financing.
He is a graduate of Syracuse University and Boston College Law School.
can be reached at email@example.com
The Biotech Boom: What We Can Learn From a Banner Year » Oxbridge Biotech Roundtable
Peter B. Finn, Rubin and Rudman LLP